在玻璃中从聚合物核心/外纳米粒子通过多尺度建模的镜头释放
Tommaso Casalini1, Kevin Treacher2, Iain Grant3
1Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 11115 - 98499, Sweden.
Molecular pharmaceutics
|April 30, 2024
概括
用于癌症治疗的纳米粒子的多尺度建模揭示了药物释放机制. 这种方法结合了分子动力学和宏观模型,以了解药物分区和释放动力学,支持实验验证.
科学领域:
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
- 计算化学的计算化学
背景情况:
- 纳米粒子在癌症治疗中具有优势,包括药物保护和向输送.
- 数学建模有助于优化纳米粒子设计,但多尺度现象带来了挑战.
- 目前的实验方法可能无法完全阐明纳米粒子释放机制.
研究的目的:
- 研究用于癌症治疗的聚合物核心/外纳米颗粒的体外释放.
- 采用多尺度建模方法来弥合不同的时间和长度尺度.
- 为了阐明作为一种疏水离子离子对组装的活性化合物的释放机制.
主要方法:
- 利用分子动力学模拟来跟踪原子级药物分子.
- 开发了一个宏观模型来描述释放率和机制.
- 对实验数据验证了宏观模型.
主要成果:
- 药物主要在聚合物中进行分离,并以疏水离子离子对的形式释放,而不是自由分子.
- 疏水性离子对在释放介质中首选分成Tween 20粒.
- 多尺度建模为释放机制提供了洞察力,这些机制难以通过实验获得.
结论:
- 多尺度建模方法成功证实了实验发现.
- 从纳米颗粒中获得了对药物释放机制的重要见解.
- 这种方法支持开发和验证基于纳米粒子的癌症治疗的预测释放模型.
更多相关视频
相关概念视频
In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Dissolution: Alternative Methods
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


